Clinica del Mediterraneo, Ragusa, Italy.
Centro Aster, Catania, Italy.
Gynecol Obstet Invest. 2024;89(1):50-58. doi: 10.1159/000534860. Epub 2023 Oct 30.
Luteinizing hormone (LH) plays a key role in normal follicular development and oocyte maturation in controlled ovarian stimulation. LH stimulates the proliferation and differentiation of theca cells for the secretion of androgens, synergistically increasing estrogen production. This study aimed to investigate the effects of low LH concentrations on oocyte retrieval, fertilization, and embryo development in patients undergoing in vitro fertilization/intracytoplasmic sperm injection.
We prospectively (ClinicalTrials ID: NCT05755529) analyzed patients undergoing in vitro fertilization/intracytoplasmic sperm injection, subdividing them into three groups according to their age. Serum LH levels were evaluated on day 3, during stimulation (day 10) and before ovulation induction (day 12).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Forty-three consecutive women were scheduled for IVF and received ovarian stimulation with follitropin alfa (Gonal F, Merck Serono, Germany) and ganirelix (Fyremaldel, Sun Pharma, Italy). Statistical analysis was performed with InStat 3.10, GraphPad software, San Diego, CA, USA. Normal distribution was tested by the Shapiro-Wilk test. Continuous variables were expressed as the mean and standard deviation. Categorical variables are expressed as frequencies and percentages.
Our data analysis suggests that serum LH levels progressively decrease during controlled ovarian stimulation, and this effect is more evident in the early phase of this procedure. From this perspective, circulating LH levels may significantly decrease during the late follicular phase due to the negative feedback of ovarian hormones from multiple follicular developments or after the suppressive effects of gonadotropin-releasing hormone antagonists.
Although our study confirms that exogenous LH can be considered a strategy in women with reduced LH levels during ovarian stimulation to improve oocyte quality and reproductive outcome, the generalizability of the results is limited by the low number of participants enrolled.
Exogenous LH may be considered a strategy in women with a decrease in LH levels during ovarian stimulation to improve oocyte quality and reproductive outcome.
黄体生成素(LH)在控制性卵巢刺激中对正常卵泡发育和卵母细胞成熟起着关键作用。LH 刺激颗粒细胞的增殖和分化,以分泌雄激素,协同增加雌激素的产生。本研究旨在探讨在接受体外受精/胞浆内精子注射的患者中,低 LH 浓度对卵母细胞回收、受精和胚胎发育的影响。
我们前瞻性地(临床试验 ID:NCT05755529)分析了接受体外受精/胞浆内精子注射的患者,根据年龄将他们分为三组。在第 3 天、刺激期间(第 10 天)和排卵诱导前(第 12 天)评估血清 LH 水平。
参与者/材料、设置、方法:43 名连续的妇女被安排进行 IVF,并接受卵泡刺激素阿尔法(Gonal F,Merck Serono,德国)和 ganirelix(Fyremaldel,Sun Pharma,意大利)的卵巢刺激。统计分析使用 InStat 3.10、GraphPad 软件(美国圣地亚哥)进行。通过 Shapiro-Wilk 检验测试正态分布。连续变量表示为平均值和标准差。分类变量表示为频率和百分比。
我们的数据分析表明,血清 LH 水平在控制性卵巢刺激过程中逐渐降低,这种效应在该过程的早期更为明显。从这个角度来看,由于多个卵泡发育或促性腺激素释放激素拮抗剂的抑制作用,循环 LH 水平可能会在晚期卵泡期显著降低。
尽管我们的研究证实,在外源性 LH 可以被认为是一种策略,在妇女与减少 LH 水平在卵巢刺激,以改善卵母细胞质量和生殖结局,结果的普遍性是有限的,由低数量的参与者注册。
在外源性 LH 可以被认为是一种策略,在妇女与减少 LH 水平在卵巢刺激,以改善卵母细胞质量和生殖结局。